.png)
Mid-Size Medtech
Clinical & Scientific Affairs, HEOR, Market Access
Commercialized Medical Device
Oncology
Subscribe to our newsletter to receive the latest case studies.
Mid-Size Medtech
Clinical & Scientific Affairs, HEOR, Market Access
Commercialized Medical Device
Oncology
A mid-size medtech company had commercialized an innovative oncology technology but faced evolving evidence expectations, reimbursement requirements, and stakeholder demands.
As the market matured, teams needed greater clarity on value positioning, target populations, and the evidence required to support broader adoption.
The client engaged Alkemi to assess market access barriers, align internal stakeholders, and develop a strategy to support long-term adoption and growth.
1. Assessed the evidence landscape, reimbursement environment, clinical guidelines, and stakeholder decision drivers.
2. Conducted a cross-functional workshop to align teams on value positioning, target populations, and market access priorities.
3. Identified key evidence gaps, adoption barriers, and stakeholder engagement opportunities.
4. Developed a strategic roadmap and value communication framework to guide future access efforts.
Align evidence, positioning, and access strategy around a shared path to adoption.
"Alkemi helped us connect evidence, stakeholder perspectives, and market access priorities into a cohesive strategy that will guide our future efforts." - Senior VP, Scientific & Clinical Affairs
Established a shared value narrative and market access framework across functions.
Identified the evidence, positioning, and engagement activities most critical to adoption.
Created a roadmap to guide future evidence generation, stakeholder outreach, and market access execution.